Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A04 ANTIEMETICS AND ANTINAUSEANTS
A04A ANTIEMETICS AND ANTINAUSEANTS
A04AD Other antiemetics
A04AD14 Rolapitant
D08988 Rolapitant hydrochloride (USAN) <US>
USP drug classification [BR:br08302]
Antiemetics
Emetogenic Therapy Adjuncts
Rolapitant
D08988 Rolapitant hydrochloride (USAN)
Drug groups [BR:br08330]
Gastrointestinal agent
DG01762 Antiemetic
DG01868 Rolapitant
D08988 Rolapitant hydrochloride
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG01868 Rolapitant
D08988 Rolapitant hydrochloride
Metabolizing enzyme inhibitor
DG01645 CYP2D6 inhibitor
DG01868 Rolapitant
D08988 Rolapitant hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Tachykinin
TACR1 (NK1R)
D08988 Rolapitant hydrochloride (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D08988
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D08988
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D08988
Drug groups [BR:br08330]
Gastrointestinal agent
DG01762 Antiemetic
DG01868 Rolapitant
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG01868 Rolapitant
Metabolizing enzyme inhibitor
DG01645 CYP2D6 inhibitor
DG01868 Rolapitant